Apoptosis: A two-edged sword in aging

Anticancer Research

Volumn 19, Issue 4 B, 1999, Pages 2837-2842

  Warner, Huber R ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Aging; Apoptosis

Indexed keywords

AGING; APOPTOSIS; AUTOIMMUNITY; CANCER INCIDENCE; CARDIOVASCULAR DISEASE; HUMAN; MITOSIS; NERVE DEGENERATION; OSTEOPOROSIS; OXIDATIVE STRESS; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

AGING; APOPTOSIS; AUTOIMMUNITY; DNA REPAIR; HUMANS; MITOSIS; NEOPLASMS; OSTEOPOROSIS;

EID: 0033452557     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. Columbano A: Cell death: Current difficulties in discriminating apoptosis from necrosis in the context of pathological processes in vivo. J Cell Biochem 58: 181-190, 1995.
2. Kerr JFR, Wyllie AH and Currie AR: Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257, 1972.
3. Raff M. Cell suicide for beginners. Nature 396: 119-122, 1998.
4. Nagata S, and Golstein P: The Fas death factor. Science 267: 1449-1456, 1995.
5. Ogawa N, Dang N, and Talal N: Apoptosis and autoimmunity. J Autoimmun 8: 1-19, 1995.
6. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462, 1995.
7. Vaux DL, Cory S, and Adams J: Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335: 440-442, 1988.
8. Williams GT: Programmed cell death: Apoptosis and oncogenesis. Cell 65: 1097-1098, 1991.
9. Warner HR, Hodes RJ, and Pocinki K: What does cell death have to do with aging? J Am Ger Soc 45: 1140-1146, 1997.
10. Ellis RE, Yuan J, and Horvitz HR: Mechanisms and functions of cell death. Ann Rev Cell Biol 7: 663-698, 1991.
11. Adams JM, and Corey S: The Bcl-2 protein family: Arbiters of cell survival. Science 281: 1322-1325, 1998.
12. Thornberry NA, and Lazebnik Y: Caspases: enemies within. Science 281: 1312-1316, 1998.
13. Clem RJ, Cheng EH-Y, Karp CL, Kirsch DG, Ueno K, Takahashi A, Kastan MB, Griffin DE, Earnshaw WC, Veliuona MA, and Hardwick JM: Modulation of cell death by Bcl-XL through caspase interaction. Proc. Natl. Acad. Sci. USA 95: 554-559, 1998.
14. Fattman CL, An B, and Dou QP. Characterization of interior cleavage of retinoblastoma protein in apoptosis. J. Cell. Biochem. 67: 399-408, 1997.
15. Tewari M, Quan LT, OlRourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesan GS, and Dixit VM. Yama/CPP32ß, a mammalian homolog of ced-3, is a CrmA-inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase. Cell 81: 801-809, 1995.
16. x but not CPP32: Multiple interleukin 1ß-converting enzyme-related proteases with distinct substrate recognition properties arc active in apoptosis. Proc Natl Acad Sci USA 93: 8345-8400, 1996.
17. Kayalar C, Örd T, Testa MP, Zhong L-T, and Bredesen DE: Cleavage of actin by interleukin 1ß-converting enzyme to reverse DNase I inhibition. Proc. Natl. Acad. Sci. USA 43: 2234-2238, 1996.
18. Liu X, Zou H, Slaughter C, and Wang X: DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 89: 175-184, 1997.
19. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, and Nagata S: A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 341: 43-50, 1998.
20. Levine A: p53, the cellular gatekeeper for growth and division. Cell 88: 323-331, 1997.
21. Weindruch R: Dietary restriction, tumors, and aging in rodents. J Gerontol 44: 67-71, 1989.
22. Grasl-Kraupp B, Bursh W, Ruttkay-Nedecky B, Wagner A, Lauer B, and Schulte-Hermann R: Food restriction eliminates preneoplastic cells through apoptosis and antagonizes carcinogenesis in rat liver. Proc. Natl. Acad. Sci. USA 91: 9995-9999, 1994.
23. James SJ, and Muskhelishvili L: Rates of apoptosis and proliferation vary with caloric intake and may influence incidence of spontaneous hepatoma in C57BL/6 x C3HF1 mice. Cancer Res 54: 5508-5510, 1994.
24. Holt PR, Moss SF, Heydari AR, and Richardson A: Diet restriction increases apoptosis in the gut of aging rats. J Gerontol 53A: B168-172, 1998.
25. Warner HR, Fernandes G, and Wang E: A unifying hypothesis to explain the retardation of aging and tumorigenesis by caloric restriction. J Gerontol 50A: B107-109, 1995.
26. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Kinskens M, Rubeli I, Pereira-Smith O, Peacocke M, and Campisi J: A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92: 9363-9367.
27. Wang E: Senescent human fibroblasts resist programmed cell death and failure to suppress bcl-2 is involved. Cancer Res 55: 2284-2292, 1995.
28. Wang E, Lee MJ, and Pandey S: Control of fibroblast senescence and activation of programmed cell death. J Cell Biochem 54: 432-434, 1994.
29. Millis AJ, Hoyle M, McCue HM, and Martini H: Differential expression of metalloproteinase and tissue inhibitor of metalloproteinase genes in aged human fibroblasts. Exp Cell Res 201: 373-379, 1992.
30. Campisi J: Aging and cancer: The double edged sword of replicative senescence. J Am Ger Soc 45: 482-488, 1997.
31. Masson R, Lefebvre O, Noאl A, El Fahine M, Chenard MP, Wendling C, Kebers F, LeMeur M, Dierich A, Foidart JM, Basset P, and Rio MC: In vivo evidence that stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy. J Cell Biol 140: 1535-1541, 1998.
32. Jacobson MD, Weil U, and Raft MC: Programmed cell death in animal development. Cell 88: 347-354, 1997.
33. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, and Nagata S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356: 314-317, 1992.
34. Takahaski T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, and Nagata S: Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76: 969-976, 1994.
35. Luan X, Zhao W, Chandrasekar B, and Fernandes G: Calorie restriction modulates lymphocyte subset phenotype and increases apoptosis in MRL/lpr mice. Immunol Lett 47: 181-186, 1995.
36. Rieux-Lancat F, LeDeist F, Hivroz C, Roberts IA, Debatin KM, Fischer A., and deVillartay JP. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268: 1347-1349, 1995.
37. Fisher GH, Rosenberg FJ, Straus SE, Dale JF, Middeton LA, Lin AY, Strober W, Lenardo MJ, and Puck JM: Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative disease. Cell 81: 935-946, 1995.
38. Aringer M, Wintersberger W, Steiner CW, Kiener H, Presterl E, Jaeger U, Smolen JS, and Graninger WB: High levels of bcl-2 protein in circulating T-lymphocytes, but not B-lymphocytes, of patients with systemic lupus erythematosus. Arthritis Rheum 37: 1423-1430, 1994.
39. Zhou T, Edwards CK, and Mountz JD: Prevention of age-related T cell apoptosis defect in CD2-faz-transgenic mice. J Exp Med 182: 129-137, 1995.
40. Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, and Boyce BF: Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-ß. Nature Med 2: 1132-1136, 1996.
41. Okahashi N, Koide M, Jimi E, Suda T, and Nishihara T: Caspases (interleukin-1ß-converting enzyme family proteases) are involved in the regulation of the survival of osteoclasts. Bone 23: 33-41, 1998.
42. Rogers MJ, Chilton KM, Coxom FP, Lawry J, Smith MO, Suri S, and Russell RG: Bisphosphonates induce apoptosis in mouse macrophage-like cells in vitro by a nitric oxide-independent mechanism. J Bone Mineral Res 11: 1482-1491, 1996.
43. Van L-J, Levine RL, and Sohal RS: Oxidative damage during aging targets mitochondrial aconitase. Proc Natl Acad Sci USA 94: 11168-11172, 1997.
44. Van L-J, and Sohal RS: Mitochondrial adenine nucleotide translocase is modified oxidatively during aging. Proc. Natl. Acad. Sci. USA 95: 12896-12901, 1998.
45. Graham BH, Waymire KG, Cottrell B, Trounce IA, MacGregor GR, and Wallace DC: A mouse model for mitochondrial myopathy resulting from a deficinecy in the heart/muscle isoform of the adenine nucleotide translocator. Nature Genetics 16: 226-234, 1997.
46. Nieminen A-L, Saylor AK, Tesfai SA, Herman B, and Lemasters JJ: Contribution of the mitochondrial permeability transition to lethal injury after exposure of hepatocytes to t-butylhydroperoxide. Biochem J 307: 99-106, 1995.
47. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng T, Jones DP, and Wang X: Prevention of apoptosis by bcl-2: Release of cytochrome c from mitochondria blocked. Science 275: 1129-1132, 1997.
48. Green DR, and Reed JC: Mitochondria and apoptosis. Science 281: 1309-1312, 1998.
49. Smale G, Nicholas NR, Brady DR, Finch CE, and Horton WE, Jr: Evidence for apoptotic cell death in Alzheimer's disease. Exp. Neurol 133: 225-230, 1995.
50. Cotman CW, and Anderson AJ: A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol Neurobiol 10: 19-45, 1995.
51. Dragunow M, Faull RL, Lawlor P, Beilharz EJ, Singleton K, Walker EB, and Mee E: In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimers disease temporal lobes. Neuroreport 9: 1053-1057, 1995.
52. Thomas LB, Gates DJ, Richfield EK, O£Brien TF, Schweitzer JB, and Steinder DA: DNA end labelling (TUNEL) in Huntington's disease and other neuropathological conditions. Exp Neurol 133: 265-272, 1995.
53. Kostic V, Jackson-Lewis V, de Bilbao F, Dubois-Dauphin M, and Przedborski S: Bcl-2: prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science 277: 559-562, 1997.
54. Friedlander RM, Brown RH, Gagliardini U, Wang J, and Yuan J. Inhibition of ICE slows ALS in mice. Nature 388: 31, 1997.
55. Hara H, Friedlander RM, Gagliardini V, Ayata C, Fink K, Huang Z, Shimizu-Sasamata M, Yuan J, and Moskowitz MA: Inhibition of interleukin 1ß converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc Natl Acad Sci USA 94: 2007-2012, 1997.
56. Milligan CE, Prevette D, Yaginuma H, Homma S, Cardwell C, Fritz LC, Tomaselli KJ, Oppenheim RW, and Schwartz LM: Peptide inhibitors of the ICE protease family arrest programmed cell death of neurons in vivo and in vitro. Neuron 15: 385-393, 1995.
57. Friedlander RM, Gagliardini V, Hara H, Fink KB, Li W, MacDonald G, Fishman MC, Greenberg AH, Moskowitz MA, and Yuan J: Expression of a dominant negative mutant of interleukin-1ß converting enzyme in transgenic mice prevents neuronal cell death induced by trophic factor withdrawal and ischemic brain injury. J Exp Med 185: 933-940, 1997.
58. Barinaga M: Stroke-damaged neurons may commit cellular suicide. Science 281: 1302-1303, 1998.
59. Barinaga M: Is apoptosis key in Alzeimer's disease? Science 281: 1303-1304, 1998.
60. Yang G, Chan PH, Chen J, Carlson E, Chen SF, Weinstein P, Epstein CJ, and Kamii H: Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischemia. Stroke 25: 165-170, 1994.
61. Parkes TL, Elia AJ, Dickinson D, Hilliker AJ, Phillips JP, and Boulianne GL: Extension of Drosophila lifespan by overepression of human SODI in motor neurons. Nature Genetics 19: 171-174, 1998.
62. Travis GH: Mechanisms of cell death in inherited retinal degeneration. Am J Hum Genet 62:503-508, 1998.
63. Humphries MM, Rancourt D, Farrar GJ, Kenna P, Hazel M, Bush RA, and Sieving PA: Retinopathy induced in mice by targeted disruption of the rhodopsin gene. Nature Genet 15: 216-219, 1997.
64. Davidson FF, and Stellar H: Blocking apoptosis prevents blindness in Drosophila retinal degeneration mutants. Nature 391: 587-591, 1998.
65. Li Y, Huang T.-T, Carlson EJ, Melov S, Ursell PC, Olson JL, Noble LJ, Yoshimura MP, Berger C, Chan PH, Wallace DC, and Epstein CJ: Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet 11: 376-381, 1995.
66. Lebovitz RM, Zhang H, Vogel H, Cartwright J, Dionne L, Lu N, Huang S, and Matzuk MM: Neurodegeneration, myocardial injury, and perinatal death in mitochondrial superoxide dismutase-deficient mice. Proc Natl Acad Sci USA 93: 9782-9787, 1996.
67. Williams MD, Van Remmen H, Conrad CC, Huang T-.T, Epstein CJ, and Richardson A: Increased oxidative damage is correlated to altered mitochondrial function in heterozygous manganese dismutase knockout mice. J Biol Chem 273: 28510-28515, 1998.
68. Saraste A, Pulkki K, Kallajoki M, Hendriksen K, Parvinen M, and Voipio-Pulkki LM: Apoptosis in human acute myocardial infarction. Circulation 95: 320-323, 1997.
69. Kajstura J, Cheng W, Reiss K, Clark WA, Sonnenblick EH, Krajewski S, Reed JC, Olivetti G, and Anversa P: Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest 74: 86-107, 1996.
70. Lee CM, Chung SS, Kaczkowski JM, Weindruch R, and Aiken JM: Multiple mitochondrial DNA deletions associated with age in skeletal muscle of rhesus monkeys. J Gerontology 48: B201-205, 1993.